Related references
Note: Only part of the references are listed.2 The impact of hepatitis C virus outside the liver: Evidence from Asia
Zobair M. Younossi et al.
LIVER INTERNATIONAL (2017)
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study
Katja Deterding et al.
LANCET INFECTIOUS DISEASES (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection
Lynn Gerber et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy
Julia Hengst et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Jean-Michel Pawlotsky
GASTROENTEROLOGY (2016)
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2016)
TREATMENT OF HEPATITIS C VIRUS IN PATIENTS WITH ADVANCED CIRRHOSIS: ALWAYS JUSTIFIED? ANALYSIS OF THE HEPA-C REGISTRY
C. Fernandez-Carrillo et al.
JOURNAL OF HEPATOLOGY (2016)
Future landscape of hepatitis C research - Basic, translational and clinical perspectives
Darius Moradpour et al.
JOURNAL OF HEPATOLOGY (2016)
Who to test and how to test for chronic hepatitis C infection-2016 WHO testing guidance for low- and middle-income countries
Philippa J. Easterbrook
JOURNAL OF HEPATOLOGY (2016)
SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN PATIENTS CO-INFECTED WITH HCV AND HIV-1: THE PHASE 3 ASTRAL-5 STUDY
D. Wyles et al.
JOURNAL OF HEPATOLOGY (2016)
SIX WEEKS OF SOFOSBUVIR/ LEDIPASVIR (SOF/LDV) ARE SUFFICIENT TO TREAT ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: THE HEPNET ACUTE HCV IV STUDY
K. Deterding et al.
JOURNAL OF HEPATOLOGY (2016)
The hepatitis delta virus: Replication and pathogenesis
Camille Sureau et al.
JOURNAL OF HEPATOLOGY (2016)
HIGH SUSTAINED VIROLOGICAL RESPONSE RATES USING GENERIC DIRECT ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C, IMPORTED INTO AUSTRALIA
J. Freeman et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus
Z. M. Younossi et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus
Z. M. Younossi et al.
JOURNAL OF VIRAL HEPATITIS (2016)
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Jeffrey D. Stanaway et al.
LANCET (2016)
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns et al.
LANCET INFECTIOUS DISEASES (2016)
Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity
Issah Younossi et al.
PSYCHOSOMATICS (2016)
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study
George Lau et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection A Randomized Trial
Stefan Zeuzem et al.
ANNALS OF INTERNAL MEDICINE (2015)
Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Michael P. Curry et al.
GASTROENTEROLOGY (2015)
Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
Francesco Negro et al.
GASTROENTEROLOGY (2015)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
Raymond T. Chung et al.
HEPATOLOGY (2015)
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Xavier Forns et al.
HEPATOLOGY (2015)
Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios
Ingmar Wolffram et al.
JOURNAL OF HEPATOLOGY (2015)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
Strategies to manage hepatitis C virus infection disease burden - volume 3
F. Z. Alfaleh et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2
E. Gane et al.
JOURNAL OF VIRAL HEPATITIS (2015)
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2
A. Hatzakis et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2
V. Saraswat et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
David Roth et al.
LANCET (2015)
Treatment of Hepatitis C in Liver Transplant Patients: Interferon Out, Direct Antiviral Combos In
Jennifer C. Price et al.
LIVER TRANSPLANTATION (2015)
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
M. P. Curry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
G. R. Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review
Yukio Osaki et al.
HEPATOLOGY RESEARCH (2015)
OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naive patients with HIV/HCV genotype 2/3 co-infection in Italy
Raffaele Bruno et al.
LIVER INTERNATIONAL (2015)
Current and future HCV therapy: do we still need other anti-HCV drugs?
Salvatore Petta et al.
LIVER INTERNATIONAL (2015)
The impact of hepatitis C burden: an evidence-based approach
Z. M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Multiple Factors Predict Physical Performance in People with Chronic Liver Disease
Anthony Loria et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2014)
The past, present and future of neutralizing antibodies for hepatitis C virus
Jonathan K. Ball et al.
ANTIVIRAL RESEARCH (2014)
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
Jane Scott et al.
BMC INFECTIOUS DISEASES (2014)
Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?
Axel J. Schmidt et al.
BMC PUBLIC HEALTH (2014)
Mechanisms of HCV-induced liver cancer: What did we learn from in vitro and animal studies?
Ivan Rusyn et al.
CANCER LETTERS (2014)
Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
Adriano M. Pellicelli et al.
DIGESTIVE AND LIVER DISEASE (2014)
Liver Environment and HCV Replication Affect Human T-Cell Phenotype and Expression of Inhibitory Receptors
Daniela C. Kroy et al.
GASTROENTEROLOGY (2014)
Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
Christophe Hezode et al.
GASTROENTEROLOGY (2014)
Monitoring and Treatment of Inactive Chronic Hepatitis B: Is It Cost-Effective?
Zobair Younossi et al.
HEPATOLOGY (2014)
All-Oral Combination of Ledipasvir, Vedroprevir, Tegobuvir, and Ribavirin in Treatment-Naive Patients With Genotype 1 HCV Infection
David L. Wyles et al.
HEPATOLOGY (2014)
Immune Responses to HCV and Other Hepatitis Viruses
Su-Hyung Park et al.
IMMUNITY (2014)
Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C
Stéphane Chevaliez et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection
Huiying Rao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing
Thomas F. Baumert et al.
JOURNAL OF HEPATOLOGY (2014)
Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Innate and adaptive immune responses in HCV infections
Markus H. Heim et al.
JOURNAL OF HEPATOLOGY (2014)
Worker Productivity Outcome Measures: OMERACT Filter Evidence and Agenda for Future Research
Kenneth Tang et al.
JOURNAL OF RHEUMATOLOGY (2014)
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H. Razavi et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Strategies to manage hepatitis C virus (HCV) disease burden
H. Wedemeyer et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Indications for Testing Among Reported Cases of HCV Infection From Enhanced Hepatitis Surveillance Sites in the United States, 2004-2010
Reena Mahajan et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2013)
Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa
D. Kania et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: Possible implications for sclerosing cholangitis
Marco Marzioni et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term clearance of hepatitis C virus following interferon-2b or peginterferon-2b, alone or in combination with ribavirin
M. P. Manns et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Hepatitis C Virus Infection Induces Inflammatory Cytokines and Chemokines Mediated by the Cross Talk between Hepatocytes and Stellate Cells
Hironori Nishitsuji et al.
JOURNAL OF VIROLOGY (2013)
Sofosbuvir: the final nail in the coffin for hepatitis C?
Michael P. Manns et al.
LANCET INFECTIOUS DISEASES (2013)
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial
Katja Deterding et al.
LANCET INFECTIOUS DISEASES (2013)
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Troels K. H. Scheel et al.
NATURE MEDICINE (2013)
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Barbara Rehermann
NATURE MEDICINE (2013)
Novel therapies for hepatitis C - one pill fits all?
Michael P. Manns et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
Amit Kapoor et al.
MBIO (2013)
Liver transplantation in the setting of chronic HCV
Norah Terrault
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
New Virologic Tools for Management of Chronic Hepatitis B and C
Stephane Chevaliez et al.
GASTROENTEROLOGY (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence
Julian Schulze zur Wiesch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
THE EFFECT OF RENAL IMPAIRMENT AND END STAGE RENAL DISEASE ON THE SINGLE-DOSE PHARMACOKINETICS OF PSI-7977
M. T. Cornpropst et al.
JOURNAL OF HEPATOLOGY (2012)
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
Peter D. Burbelo et al.
JOURNAL OF VIROLOGY (2012)
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
Jason Grebely et al.
LANCET INFECTIOUS DISEASES (2012)
Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
Anna S. Lok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Phylogeography, Risk Factors and Genetic History of Hepatitis C Virus in Gabon, Central Africa
Richard Njouom et al.
PLOS ONE (2012)
A Review of Patient-Reported Outcome Labels in the United States: 2006 to 2010
Ari Gnanasakthy et al.
VALUE IN HEALTH (2012)
Polyfunctional Type-1, -2, and -17 CD8+ T Cell Responses to Apoptotic Self-Antigens Correlate with the Chronic Evolution of Hepatitis C Virus Infection
Debora Franceschini et al.
PLOS PATHOGENS (2012)
Nonprimate Hepaciviruses in Domestic Horses, United Kingdom
Sinead Lyons et al.
EMERGING INFECTIOUS DISEASES (2012)
High genetic diversity including potential new subtypes of hepatitis C virus genotype 6 in Lao People's Democratic Republic
J. M. Huebschen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Seroprevalence and Genotype of Hepatitis C Virus among Immigrant Workers from Cambodia and Myanmar in Thailand
Srunthron Akkarathamrongsin et al.
INTERVIROLOGY (2011)
Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid
Stephen R. Lee et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
Characterization of a canine homolog of hepatitis C virus
Amit Kapoor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hepatitis C virus genotypes in Pakistan: a systemic review
Sobia Attaullah et al.
VIROLOGY JOURNAL (2011)
Liver Transplantation in the United States, 1999-2008
P. J. Thuluvath et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
Mark G. Swain et al.
GASTROENTEROLOGY (2010)
Predictors of health-related quality of life in patients with chronic liver disease
A. Afendy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C
Ava A. John-Baptiste et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Diagnoses of, and deaths from, severe liver disease due to hepatitis C in England between 2000 and 2005 estimated using multiple data sources
A. G. Mann et al.
EPIDEMIOLOGY AND INFECTION (2009)
Coinfection With HIV-1 and HCV-A One-Two Punch
Arthur Y. Kim et al.
GASTROENTEROLOGY (2009)
Pilot Study of Postexposure Prophylaxis for Hepatitis C Virus in Healthcare Workers
Kathleen E. Corey et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice
Stephane Chevaliez et al.
PLOS ONE (2009)
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation
M. Berenguer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Hepatitis C virus genotypes in two different patient cohorts in Johannesburg, South Africa
Nishi Prabdial-Sing et al.
ARCHIVES OF VIROLOGY (2008)
Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study
Oidov Baatarkhuu et al.
LIVER INTERNATIONAL (2008)
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
Jennifer M. Timpe et al.
HEPATOLOGY (2008)
Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection
Jillian Kallman et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtype
Aye Aye Lwin et al.
HEPATOLOGY RESEARCH (2007)
Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma
Mohamed Abdel-Hamid et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression
Henry Radziewicz et al.
JOURNAL OF VIROLOGY (2007)
Treating hepatitis C infection in liver transplant recipients
Norah A. Terrault et al.
LIVER TRANSPLANTATION (2006)
Interferon gamma-secreting HCV-specific CD8+T cells in the liver of patients with chronic C hepatitis:: relation to liver fibrosis -: ANRS HC EP07 study
N. Bonilla et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET Acute-HCV-II Study
J Wiegand et al.
HEPATOLOGY (2006)
Changing pattern of hepatitis C virus spread in rural areas of Egypt
N Arafa et al.
JOURNAL OF HEPATOLOGY (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Hepatitis C virus infection in Cameroon: A cohort-effect
E Nerrienet et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo et al.
SCIENCE (2004)
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma
MYW Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effectiveness of Interferon α-2b and Ribavirin Combination Therapy in the Treatment of Naive Chronic Hepatitis C Patients in Clinical Practice
Thomas M. Shehab et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
N Qurishi et al.
LANCET (2003)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
D Lamarre et al.
NATURE (2003)
HCV persistence and immune evasion in the absence of memory T cell help
A Grakoui et al.
SCIENCE (2003)
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers
CL Day et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C
RH Wiesner et al.
LIVER TRANSPLANTATION (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication
M Bouvier-Alias et al.
HEPATOLOGY (2002)
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles
P André et al.
JOURNAL OF VIROLOGY (2002)
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan
R Ruzibakiev et al.
INTERVIROLOGY (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Interpreting SF-36 summary health measures: A response
JE Ware et al.
QUALITY OF LIFE RESEARCH (2001)
Peginterferon alfa-2a in patients with chronic hepatitis C
S Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
A Takaki et al.
NATURE MEDICINE (2000)
HCV-related fibrosis progression following liver transplantation:: increase in recent years
M Berenguer et al.
JOURNAL OF HEPATOLOGY (2000)
Genetic epidemiology of hepatitis C virus throughout Egypt
SC Ray et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
